FLORESTA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 4.022
AS - Asia 2.551
EU - Europa 2.287
SA - Sud America 434
AF - Africa 316
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.618
Nazione #
US - Stati Uniti d'America 3.940
IT - Italia 1.431
SG - Singapore 1.210
CN - Cina 828
BR - Brasile 370
IE - Irlanda 284
CI - Costa d'Avorio 228
KR - Corea 186
RU - Federazione Russa 133
VN - Vietnam 114
DE - Germania 87
GB - Regno Unito 59
CA - Canada 48
NL - Olanda 44
FI - Finlandia 41
IN - India 41
SE - Svezia 38
AR - Argentina 27
CZ - Repubblica Ceca 27
FR - Francia 27
MX - Messico 27
ES - Italia 24
PL - Polonia 24
BD - Bangladesh 23
UA - Ucraina 23
ID - Indonesia 22
JP - Giappone 22
HK - Hong Kong 19
BJ - Benin 18
TR - Turchia 18
ZA - Sudafrica 18
SN - Senegal 17
IR - Iran 15
EC - Ecuador 13
IQ - Iraq 11
AT - Austria 10
CH - Svizzera 10
CO - Colombia 9
MA - Marocco 9
AE - Emirati Arabi Uniti 7
VE - Venezuela 7
AU - Australia 6
EG - Egitto 6
NG - Nigeria 6
BE - Belgio 5
PK - Pakistan 5
UZ - Uzbekistan 5
BG - Bulgaria 4
LB - Libano 4
MY - Malesia 4
TN - Tunisia 4
AL - Albania 3
CL - Cile 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
KZ - Kazakistan 3
PY - Paraguay 3
JO - Giordania 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 9.618
Città #
Dallas 808
Singapore 670
Santa Clara 564
Chandler 439
Catania 367
Hefei 359
Chicago 300
Dublin 284
Abidjan 228
Ashburn 200
Seoul 184
Civitanova Marche 152
Beijing 148
Boardman 134
Houston 126
Los Angeles 108
Rome 69
Cambridge 59
Lawrence 59
Moscow 57
Naples 55
Andover 52
Bremen 39
Milan 38
The Dalles 35
Buffalo 34
Columbus 34
Nanjing 34
Des Moines 32
Ho Chi Minh City 31
New York 30
Lappeenranta 28
Hanoi 27
San Giovanni la Punta 26
São Paulo 26
Palermo 25
Council Bluffs 24
Jacksonville 24
Amsterdam 23
Munich 22
Brno 21
Tokyo 21
Toronto 20
Dong Ket 19
Florence 19
Warsaw 19
Brooklyn 18
Cotonou 18
Phoenix 18
Sala Baganza 18
Dakar 17
Denver 17
Messina 17
Hong Kong 16
Jakarta 16
Bari 15
Misterbianco 15
Salerno 15
San Francisco 15
Wilmington 15
Boydton 14
Washington 14
Tehran 13
Acireale 12
Rio de Janeiro 12
Belpasso 11
Orem 11
Porto San Giorgio 11
Saint Petersburg 11
Stockholm 11
Groningen 10
Lecce 10
Manchester 10
Mexico City 10
Villafranca Tirrena 10
Atlanta 9
Boston 9
Chennai 9
Johannesburg 9
Mascalucia 9
Montreal 9
Reggio Calabria 9
Seattle 9
Aci Catena 8
Belo Horizonte 8
Curitiba 8
Dhaka 8
Gravina di Catania 8
Nanchang 8
Ottawa 8
Redmond 8
Bologna 7
Foggia 7
Fortaleza 7
Hebei 7
Helsinki 7
Jiaxing 7
London 7
Paternò 7
Poplar 7
Totale 6.672
Nome #
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 151
[1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor 143
DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma 141
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 140
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 137
Carbamoyl-Decorated Cyclodextrins for Carbon Dioxide Adsorption 129
A pseudouridine isoxazolidinyl nucleoside analogue structural analysis: A morphological approach 129
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2 128
Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water 126
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 121
Design of Small Molecules for Oncological and Neurodegenerative Diseases 119
A Rare Natural Benzo[k,l]xanthene as a Turn-Off Fluorescent Sensor for Cu2+ Ion 119
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 117
Green efficient one‐pot synthesis and separation of nitrones in water assisted by a self‐assembled nanoreactor 116
Mild Friedel–Crafts Reactions inside a Hexameric Resorcinarene Capsule: C−Cl Bond Activation through Hydrogen Bonding to Bridging Water Molecules 114
Functionalization of single and multi-walled carbon nanotubes with polypropylene glycol decorated pyrrole for the development of doxorubicin nano-conveyors for cancer drug delivery 113
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study 111
Sigma-2 receptor ligands QSAR model dataset 110
Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers 110
Ammidi dell’acido rosmarinico come potenziali agenti antidiabetici 109
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design 109
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 107
New arylethanolimidazole derivatives as HO-1 inhibitors with cytotoxicity against MCF-7 breast cancer cells 107
Novel structural insight into inhibitors of heme oxygenase-1 (ho-1) by new imidazole-based compounds: Biochemical and in vitro anticancer activity evaluation 106
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 105
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 104
3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation 104
Computational tools in the discovery of FABP4 ligands: A statistical and molecular modeling approach 104
Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis 103
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 99
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5'-monophosphate glycosidase 99
The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat 99
Fourfold filtered statistical/computational approach for the identification of imidazole compounds as HO-1 inhibitors from natural products 99
Intramolecular oxidative palladium-​catalyzed diamination reactions of alkenyl sulfamates: an efficient synthesis of [1,​2,​5]​thiadiazolo-​fused piperazinones 98
A hexameric resorcinarene capsule as a hydrogen bonding catalyst in the conjugate addition of pyrroles and indoles to nitroalkenes 98
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 97
γ-Cyclodextrins as Supramolecular Reactors for the Three-component Aza-Darzens Reaction in Water 96
Development of NO-releasing sigma receptor hybrids as anticancer agents 94
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 93
H2 production by solar photoreforming of plastic materials using SiC-g-C3N4composites 92
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia 92
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents 91
Computer-Assisted Design of Peptide-Based Radiotracers 90
γ-Cyclodextrin as a Catalyst for the Synthesis of 2-Methyl-3,5-diarylisoxazolidines in Water 90
Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity 89
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 89
Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose 89
Structural, morphological, and modeling studies of N-(benzoyloxy)benzamide as a specific inhibitor of Type II inosine monophosphate dehydrogenase 88
Portable Nanocomposite System for Wound Healing in Space 88
Nature-inspired innovation: Alginic-kojic acid material for sustainable antibacterial and carbon dioxide fixation 87
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 87
Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach† 87
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 84
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 84
c-Met Receptor PET Imaging Probes for Cancer Detection and Monitoring 83
‘Main Mechanical Forces‐Chemical Interactions’ Interplay as a Tool to Elucidate Folding Mechanisms 82
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 82
Physicochemical characterization and antioxidant activity evaluation of idebenone/hydroxypropyl-β-cyclodextrin inclusion complex 82
Learning Strategies from Nature's Blueprint to Cyclic Carbonate Synthesis 80
Illuminating the Path to Target GPCR Structures and Functions 79
Conversion of VOC-derived CO2 into sustainable products with a natural magnetic alginate composite 79
An integrated pharmacophore/docking/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin a inhibitors 79
Supramolecular biomaterials as drug nanocontainers with iron depletion properties for antimicrobial applications 79
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022 78
Evidence-based successful example of a structure-based approach for the prediction of designer fentanyl-like molecules 77
FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets 77
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques 77
Developing Advanced Antibacterial Alginic Acid Biomaterials through Dual Functionalization 74
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors 74
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022 73
HEMA-based macro and microporous materials for CO2 capture 72
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors 72
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes 72
Towards identifying nicomorphine administration in doping control: Synthesis of metabolites 72
Synergic Interplay Between Halogen Bonding and Hydrogen Bonding in the Activation of a Neutral Substrate in a Nanoconfined Space 71
Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid 70
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach 70
Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors 70
Current Chemistry behind Peptide-based PET Probes 11C and18F 69
Evidence of enzyme-mediated transesterification of synthetic cannabinoids with ethanol: potential toxicological impact 69
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis 68
Halloysite-kojic acid conjugate: A sustainable material for the photocatalytic CO2 reduction and fixation for cyclic carbonates production 68
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes 67
Unveiling the chemistry of antibody conjugation for enhanced PET imaging: Current trends and future directions 66
Semaglutide as a Possible Calmodulin Binder: Ligand-Based Computational Analyses and Relevance to Its Associated Reward and Appetitive Behaviour Actions 66
Solvent-free conversion of CO2 in carbonates through a sustainable macroporous catalyst 65
Designing a monolithic photo-Fenton catalyst using a fungal hydroxypyrone metabolic derivative 64
Supramolecular host-guest interactions of pseudoginsenoside F11 with β- and γ-cyclodextrin: Spectroscopic/spectrometric and computational studies 64
Structure-based approach for the prediction of mu-opioid binding affinity of unclassified designer fentanyl-like molecules 64
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process 63
Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body 63
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 63
The hexameric resorcinarene capsule as an artificial enzyme: Ruling the regio and stereochemistry of a 1,3-dipolar cycloaddition between nitrones and unsaturated aldehydes 62
THP as a sensor for the electrochemical detection of H2O2 62
TiO2/Loofah–Halloysite Bio–Hybrid Composites as Efficient Systems for VOCs Removal 61
Design and synthesis of novel compounds as fatty acids binding protein inhibitors and as gallium-68 chelators for positron emission tomography 61
Natural antenna molecule in halloysite-kojic acid composite for the solar photocatalytic CO2 methanation 60
How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)? 60
Metyrapone-β-cyclodextrin supramolecular interactions inferred by complementary spectroscopic/spectrometric and computational studies 60
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 58
Totale 8.958
Categoria #
all - tutte 33.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021146 0 0 0 0 55 12 19 8 9 3 23 17
2021/2022486 20 60 27 4 86 6 77 26 38 22 12 108
2022/20231.280 93 80 57 174 107 191 20 182 255 24 68 29
2023/2024910 55 122 68 51 50 183 33 46 33 39 125 105
2024/20253.135 100 452 157 266 506 297 199 149 222 274 248 265
2025/20263.403 444 585 1.046 477 851 0 0 0 0 0 0 0
Totale 9.943